L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
Clinical trial NCT05775705 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05775705
- Sponsor
- Beijing Friendship Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.